An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers (Q44442585)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2003

Language	Label	Description	Also known as
English	An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers	scientific article published in February 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Paul D Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Aaron L Dane

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dennis W Schneck

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Michael J Warwick

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

459-471

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Optimizing the pharmacology of statins: characteristics of rosuvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of fluconazole on the pharmacokinetics of rosuvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fibrates on serum metabolic parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980089-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80089-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44442585&oldid=2240251244"